扶桑薬品工業(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|---|---|---|
東証PRM | 医薬品 | 4538/E00953 | Fuso Pharmaceutical Industries, Ltd. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|---|---|---|---|---|---|---|---|---|
2022/02/25 | 日証協 | 20,300株 | +9.38% | 13,460株 | -46.1% | 58,581株 | -34.5% | 6,460株 | +5.8% |
2022/02/18 | 日証協 | 18,560株 | -19.86% | 24,973株 | +98.62% | 89,441株 | -3.52% | 6,106株 | +54.97% |
2022/02/10 | 日証協 | 23,160株 | +7.4% | 12,573株 | -47.74% | 92,705株 | +2.92% | 3,940株 | -38.12% |
2022/02/04 | 日証協 | 21,564株 | -52.96% | 24,060株 | -40.73% | 90,072株 | -20.39% | 6,367株 | +25.83% |
2022/01/28 | 日証協 | 45,837株 | -2.56% | 40,597株 | -24.54% | 113,146株 | -0.79% | 5,060株 | -15.68% |
2022/01/21 | 日証協 | 47,040株 | +2.4% | 53,800株 | +50.29% | 114,046株 | +3.17% | 6,001株 | +300.07% |
2022/01/14 | 日証協 | 45,937株 | -0.22% | 35,797株 | +90.41% | 110,546株 | +0.46% | 1,500株 | -28.61% |
2022/01/07 | 日証協 | 46,040株 | +0.7% | 18,800株 | -7.39% | 110,045株 | +2.32% | 2,101株 | -29.9% |
2021/12/30 | 日証協 | 45,720株 | 0% | 20,300株 | 0% | 107,548株 | 0% | 2,997株 | 0% |
2021/12/24 | 日証協 | 45,720株 | -5.77% | 20,300株 | +1094.12% | 107,548株 | -4.53% | 2,997株 | +327.53% |
2021/12/17 | 日証協 | 48,520株 | -3.42% | 1,700株 | -90.92% | 112,648株 | -2.17% | 701株 | -29.97% |
2021/12/10 | 日証協 | 50,240株 | -2.29% | 18,720株 | -73.18% | 115,147株 | +1.59% | 1,001株 | -98.21% |
2021/12/03 | 日証協 | 51,420株 | +15.34% | 69,800株 | +250.75% | 113,346株 | +65.12% | 55,800株 | +1541.18% |
2021/11/26 | 日証協 | 44,580株 | +1.36% | 19,900株 | -50% | 68,646株 | -32% | 3,400株 | -61.2% |
2021/11/19 | 日証協 | 43,980株 | +5.36% | 39,800株 | +32.67% | 100,945株 | +8.16% | 8,762株 | -32.08% |
2021/11/05 | 日証協 | 36,144株 | +26.03% | 28,257株 | +5.92% | 86,727株 | +7.3% | 20,500株 | +91.59% |
2021/10/29 | 日証協 | 28,680株 | +23.94% | 26,677株 | +48.21% | 80,827株 | +6.79% | 10,700株 | +10.31% |
2021/10/22 | 日証協 | 23,140株 | -15.98% | 18,000株 | +13.21% | 75,691株 | -0.39% | 9,700株 | +26.3% |
2021/10/15 | 日証協 | 27,540株 | +9.46% | 15,900株 | -13.49% | 75,991株 | +5.38% | 7,680株 | +37.14% |
※株式分割は考慮していませんのでご注意ください。